Montelukast
Montelukast
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Van Zutphen AR, Bell EM, Browne ML, Lin S, Lin AE, Druschel CM et al. Maternal asthma medication use during pregnancy and risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol. 2015;103(11):951-61.
Nelsen LM, Shields KE, Cunningham ML, Stoler JM, Bamshad MJ, Eng PM et al. Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications. J Allergy Clin Immunol. 2012;129:251-4e1-6.
Sarkar M, Koren G, Kalra S, Ying A, Smorlesi C, De Santis M et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol. 2009;65(12):1259-64.
Cavero-Carbonell C, Vinkel-Hansen A, Rabanque-Hernández MJ, Martos C, Garne E. Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark. Birth Defects Res. 2017;109(6):452-459.
Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3: Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8.
Ali Z, Hansen AV, Ulrik CS. Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome. J Obstet Gynaecol. 2015:1-7.
Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2: Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-81.
Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1: Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007;63:363-73.
Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: A retrospective cohort study. Am J Obstet Gynecol 2001;184:90-6.
Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000;16:167-71.
- Van Zutphen AR, Bell EM, Browne ML, Lin S, Lin AE, Druschel CM et al. Maternal asthma medication use during pregnancy and risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol. 2015;103(11):951-61.
- Nelsen LM, Shields KE, Cunningham ML, Stoler JM, Bamshad MJ, Eng PM et al. Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications. J Allergy Clin Immunol. 2012;129:251-4e1-6.
- Sarkar M, Koren G, Kalra S, Ying A, Smorlesi C, De Santis M et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol. 2009;65(12):1259-64.
- Cavero-Carbonell C, Vinkel-Hansen A, Rabanque-Hernández MJ, Martos C, Garne E. Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark. Birth Defects Res. 2017;109(6):452-459.
- Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3: Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8.
- Ali Z, Hansen AV, Ulrik CS. Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome. J Obstet Gynaecol. 2015:1-7.
- Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2: Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-81.
- Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1: Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007;63:363-73.
- Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: A retrospective cohort study. Am J Obstet Gynecol 2001;184:90-6.
- Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000;16:167-71.